标题
The therapeutic prospects of N-acetylgalactosamine-siRNA conjugates
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-12-14
DOI
10.3389/fphar.2022.1090237
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Corrigendum to “siRNA: Mechanism of action, challenges, and therapeutic approaches” [Eur. J. Pharmacol. 905 (2021) 174178]
- (2022) Walhan Alshaer et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease
- (2022) Brian Tomlinson et al. Expert Opinion on Drug Metabolism & Toxicology
- Non-viral vectors for RNA delivery
- (2022) Yi Yan et al. JOURNAL OF CONTROLLED RELEASE
- Drug delivery systems for RNA therapeutics
- (2022) Kalina Paunovska et al. NATURE REVIEWS GENETICS
- Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial
- (2022) David Adams et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Pharmacokinetic and Pharmacodynamic Modeling of siRNA Therapeutics – a Minireview
- (2022) Jae Yoon Jeon et al. PHARMACEUTICAL RESEARCH
- Vutrisiran: First Approval
- (2022) Susan J. Keam DRUGS
- The growth of siRNA-based therapeutics: updated clinical studies
- (2021) M. May Zhang et al. BIOCHEMICAL PHARMACOLOGY
- Lumasiran: First Approval
- (2021) Lesley J. Scott et al. DRUGS
- Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs
- (2021) Shintaro Fumoto et al. Pharmaceutics
- Overcoming barriers by local drug delivery with liposomes
- (2021) S.G. Antimisiaris et al. ADVANCED DRUG DELIVERY REVIEWS
- Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges
- (2021) Kiara Fairman et al. BIOCHEMICAL PHARMACOLOGY
- Inclisiran: First Approval
- (2021) Yvette N. Lamb DRUGS
- Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic
- (2021) Annette I.S. van den Berg et al. JOURNAL OF CONTROLLED RELEASE
- Structural tuning of oligonucleotides for enhanced blood circulation properties of unit polyion complexes prepared from two-branched poly(ethylene glycol)-block-poly(l-lysine)
- (2021) Mitsuru Naito et al. JOURNAL OF CONTROLLED RELEASE
- Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran – results of the phase 1 inhibitor cohort
- (2021) K. John Pasi et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Advances in siRNA delivery strategies for the treatment of MDR cancer
- (2021) Md Abdus Subhan et al. LIFE SCIENCES
- Therapeutic RNA Delivery for COVID and Other Diseases
- (2021) Curtis Dobrowolski et al. Advanced Healthcare Materials
- Development of Triantennary N-Acetylgalactosamine Conjugates as Degraders for Extracellular Proteins
- (2021) Yaxian Zhou et al. ACS Central Science
- Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
- (2021) Basmah N. Aldosari et al. Pharmaceutics
- Cytosolic Delivery of Nucleic Acids: The case of Ionizable Lipid Nanoparticles
- (2021) Michele Schlich et al. Bioengineering & Translational Medicine
- Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines
- (2021) Zehua Liu et al. ADVANCED DRUG DELIVERY REVIEWS
- A Critical Review of the Efficacy and Safety of Inclisiran
- (2021) Jennifer Hardy et al. American Journal of Cardiovascular Drugs
- Crystal Structure of the Carbohydrate Recognition Domain of the Human Macrophage Galactose C-Type Lectin Bound to GalNAc and the Tumor-Associated Tn Antigen
- (2021) Adele Gabba et al. BIOCHEMISTRY
- Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1
- (2021) Yaacov Frishberg et al. Clinical Journal of the American Society of Nephrology
- Impact of lipid nanoparticle size on mRNA vaccine immunogenicity
- (2021) Kimberly J. Hassett et al. JOURNAL OF CONTROLLED RELEASE
- Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
- (2021) Sander F. Garrelfs et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interspecies Scaling of Human Clearance and Plasma Trough Exposure for Antisense Oligonucleotides: A Retrospective Analysis of Triantennary N-Acetyl Galactosamine-Conjugated and Unconjugated-Antisense Oligonucleotides
- (2021) Charvi Nanavati et al. Nucleic Acid Therapeutics
- Insight Into the Prospects for RNAi Therapy of Cancer
- (2021) Zhili Tian et al. Frontiers in Pharmacology
- The Limitless Future of RNA Therapeutics
- (2021) Tulsi Ram Damase et al. Frontiers in Bioengineering and Biotechnology
- From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies
- (2021) Hironori Adachi et al. Biomedicines
- Renal Function Decline With Small Interfering RNA Silencing Aminolevulinic Acid Synthase 1 (ALAS1)
- (2021) Hélène Lazareth et al. Kidney International Reports
- Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases
- (2021) Elias Fattal et al. ADVANCED DRUG DELIVERY REVIEWS
- Nucleic Acid Delivery for Therapeutic Applications
- (2021) Akash Gupta et al. ADVANCED DRUG DELIVERY REVIEWS
- siRNA enrichment in Argonaute 2-depleted Blattella germanica
- (2021) José Carlos Montañés et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Lipids and Lipid Derivatives for RNA Delivery
- (2021) Yuebao Zhang et al. CHEMICAL REVIEWS
- Liposome-based delivery of biological drugs
- (2021) Kosheli Thapa Magar et al. CHINESE CHEMICAL LETTERS
- Minimal physiologically based pharmacokinetic-pharmacodynamic (mPBPK-PD) model of GalNAc-conjugated siRNA disposition and gene silencing in preclinical species and humans
- (2021) Vivaswath S Ayyar et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Ligand conjugate SAR and enhanced delivery in NHP
- (2021) Richard James Holland et al. MOLECULAR THERAPY
- The current landscape of nucleic acid therapeutics
- (2021) Jayesh A. Kulkarni et al. Nature Nanotechnology
- mRNA vaccines for infectious diseases: principles, delivery and clinical translation
- (2021) Namit Chaudhary et al. NATURE REVIEWS DRUG DISCOVERY
- Small circular interfering RNAs (sciRNAs) as a potent therapeutic platform for gene-silencing
- (2021) Hartmut Jahns et al. NUCLEIC ACIDS RESEARCH
- Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
- (2021) Ai-Ming Yu et al. PHARMACOLOGY & THERAPEUTICS
- The development and improvement of ribonucleic acid therapy strategies
- (2021) Yuxi Zhao et al. Molecular Therapy-Nucleic Acids
- Recent Advances in the Delivery Carriers and Chemical Conjugation Strategies for Nucleic Acid Drugs
- (2021) Shota Oyama et al. Cancers
- Liver-Targeted Delivery of Oligonucleotides with N-Acetylgalactosamine Conjugation
- (2021) Hao Cui et al. ACS Omega
- Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration
- (2021) Manuel J. Carrasco et al. Communications Biology
- The Crystalline Nephropathies
- (2021) Mark A. Perazella et al. Kidney International Reports
- Chemistry of Lipid Nanoparticles for RNA Delivery
- (2021) Yulia Eygeris et al. ACCOUNTS OF CHEMICAL RESEARCH
- Lipid Nanoparticle–mRNA Formulations for Therapeutic Applications
- (2021) Chang Wang et al. ACCOUNTS OF CHEMICAL RESEARCH
- Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles
- (2021) Jing Wang et al. ADVANCED DRUG DELIVERY REVIEWS
- Inclisiran in lipid management: A Literature overview and future perspectives
- (2021) Pietro Scicchitano et al. BIOMEDICINE & PHARMACOTHERAPY
- Opportunities for innovation: Building on the success of lipid nanoparticle vaccines
- (2021) Jessica Huang et al. CURRENT OPINION IN COLLOID & INTERFACE SCIENCE
- The nano delivery systems and applications of mRNA
- (2021) Mingyuan Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines
- (2021) Anna K. Blakney et al. JOURNAL OF CONTROLLED RELEASE
- Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study
- (2021) Paolo Ventura et al. LIVER INTERNATIONAL
- Life of RISC: Formation, action, and degradation of RNA-induced silencing complex
- (2021) Hiro-oki Iwakawa et al. MOLECULAR CELL
- Overcoming GNA/RNA base-pairing limitations using isonucleotides improves the pharmacodynamic activity of ESC+ GalNAc-siRNAs
- (2021) Mark K Schlegel et al. NUCLEIC ACIDS RESEARCH
- GalNAc-siRNA conjugates: Prospective tools on the frontier of anti-viral therapeutics
- (2021) Lokesh Thangamani et al. PHARMACOLOGICAL RESEARCH
- Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection
- (2021) Sneha V. Gupta et al. DRUGS IN R&D
- Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
- (2021) Chandni Bardolia et al. Frontiers in Cardiovascular Medicine
- Pharmacokinetics and Pharmacodynamics of the Small Interfering Ribonucleic Acid (siRNA), Givosiran, in Patients with Acute Hepatic Porphyria
- (2020) Sagar Agarwal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Givosiran: First Approval
- (2020) Lesley J. Scott DRUGS
- Optimizing synthetic nucleic acid and protein nanocarriers: The chemical evolution approach
- (2020) Franziska Freitag et al. ADVANCED DRUG DELIVERY REVIEWS
- Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects
- (2020) Bahru A. Habtemariam et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Statins and PCSK9 inhibitors: A new lipid-lowering therapy
- (2020) Enrique Gallego-Colon et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug
- (2020) Alexandre J. Debacker et al. MOLECULAR THERAPY
- LB002ILLUMINATE-A, A PHASE 3 STUDY OF LUMASIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC, IN CHILDREN AND ADULTS WITH PRIMARY HYPEROXALURIA TYPE 1 (PH1)
- (2020) Sander Garrelfs et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
- (2020) Manisha Balwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclisiran as Adjunct Lipid-Lowering Therapy for Patients with Cardiovascular Disease: A Cost-Effectiveness Analysis
- (2020) Ning Kam et al. PHARMACOECONOMICS
- S1154 Clinical Outcomes in Patients With Acute Hepatic Porphyria Treated With Givosiran Who Stopped Hemin Prophylaxis at Study Entry: A Post Hoc Analysis of Data From the Phase 3 ENVISION Study Through Month 12
- (2020) Herbert L. Bonkovsky et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates
- (2020) Christopher R Brown et al. NUCLEIC ACIDS RESEARCH
- Prolonged cultured human hepatocytes as an in vitro experimental system for the evaluation of potency and duration of activity of RNA therapeutics: Demonstration of prolonged duration of gene silencing effects of a GalNAc-conjugated human hypoxanthine phosphoribosyl transferase (HPRT1) siRNA
- (2020) Qian Yang et al. BIOCHEMICAL PHARMACOLOGY
- To Conjugate or to Package? A Look at Targeted siRNA Delivery Through Folate Receptors
- (2020) Lidya Salim et al. Nucleic Acid Therapeutics
- Bioconjugated oligonucleotides: recent developments and therapeutic applications
- (2019) sebastien benizri et al. BIOCONJUGATE CHEMISTRY
- The current state and future directions of RNAi-based therapeutics
- (2019) Ryan L. Setten et al. NATURE REVIEWS DRUG DISCOVERY
- RNAi therapeutic and its innovative biotechnological evolution
- (2019) Yuhua Weng et al. BIOTECHNOLOGY ADVANCES
- siRNA therapeutics: a clinical reality
- (2019) Phei Er Saw et al. Science China-Life Sciences
- Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application
- (2019) Sikandar Hayat Khan Molecular Therapy-Nucleic Acids
- Lipid-based nanoparticle formulations for small molecules and RNA drugs
- (2019) Ludger M. Ickenstein et al. Expert Opinion on Drug Delivery
- Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9
- (2019) Charles A. German et al. BIODRUGS
- Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran
- (2019) Pedro Renato de Paula Brandão et al. Molecular Diagnosis & Therapy
- Nonclinical Safety Profile of Revusiran, a 1st-Generation GalNAc-siRNA Conjugate for Treatment of Hereditary Transthyretin-Mediated Amyloidosis
- (2019) Jessica E. Sutherland et al. Nucleic Acid Therapeutics
- RNA-Targeted Therapeutics
- (2018) Stanley T. Crooke et al. Cell Metabolism
- Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression
- (2018) Jennifer L.S. Willoughby et al. MOLECULAR THERAPY
- Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates
- (2018) Donald J. Foster et al. MOLECULAR THERAPY
- Defense Mechanisms against Viral Infection in Drosophila: RNAi and Non-RNAi
- (2018) Luc Swevers et al. Viruses-Basel
- Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity
- (2018) Maja M. Janas et al. Nature Communications
- Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don’t
- (2018) R.L. Juliano Nucleic Acid Therapeutics
- GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
- (2018) Aaron D. Springer et al. Nucleic Acid Therapeutics
- Circular siRNAs for Reducing Off-Target Effects and Enhancing Long-Term Gene Silencing in Cells and Mice
- (2018) Liangliang Zhang et al. Molecular Therapy-Nucleic Acids
- Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape
- (2018) Anna Lechanteur et al. Nanomaterials
- Gene Silencing using siRNA for Preventing Liver Ischaemia-Reperfusion Injury
- (2018) H. Susana Marinho et al. CURRENT PHARMACEUTICAL DESIGN
- Patisiran: First Global Approval
- (2018) Sheridan M. Hoy DRUGS
- The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute Studies
- (2018) Maja M. Janas et al. TOXICOLOGIC PATHOLOGY
- Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial
- (2018) Lawrence A. Leiter et al. DIABETES CARE
- Porphyria
- (2017) D. Montgomery Bissell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates
- (2017) Jayaprakash K. Nair et al. NUCLEIC ACIDS RESEARCH
- An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria
- (2016) Abigail Liebow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1
- (2016) Chaitali Dutta et al. MOLECULAR THERAPY
- Enhancing Endosomal Escape for Intracellular Delivery of Macromolecular Biologic Therapeutics
- (2016) Peter Lönn et al. Scientific Reports
- siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
- (2015) Shigeo Matsuda et al. ACS Chemical Biology
- Oligonucleotide Therapies: The Past and the Present
- (2015) Karin E. Lundin et al. HUMAN GENE THERAPY
- Role of Heme in Cardiovascular Physiology and Disease
- (2015) K. T. Sawicki et al. Journal of the American Heart Association
- Renaissance of mammalian endogenous RNAi
- (2014) Petr Svoboda FEBS LETTERS
- Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
- (2014) Jayaprakash K. Nair et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape
- (2013) Jerome Gilleron et al. NATURE BIOTECHNOLOGY
- Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30)
- (2010) Gösta Holmgren et al. CLINICAL GENETICS
- CLINICAL TRIALS AND TRANSLATIONAL MEDICINE COMMENTARY: Drug Delivery Trends in Clinical Trials and Translational Medicine: Challenges and Opportunities in the Delivery of Nucleic Acid-Based Therapeutics
- (2010) Long Xu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now